VGX Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for VGX Pharmaceuticals, Inc..The latest application filed is for "smallpox dna vaccine and the antigens therein that elicit an immune response".

Company Profile

0.14.5

VGX Pharmaceuticals, Inc. - Plymouth Meeting PA
VGX Pharmaceuticals, Inc. - Blue Bell PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Electroporation devices and methods of using same for electroporation of cells in mammals Grant 9,452,285 - Draghia-Akli , et al. September 27, 2	2016-09-27
Compositions comprising GHRH and GnRH and methods of using the same Grant 8,962,818 - Draghia-Akli , et al. February 24, 2	2015-02-24
Antibody production elicited by a DNA vaccine delivered by electroporation Grant 8,927,508 - Draghia-Akli , et al. January 6, 2	2015-01-06
Optimized high yield synthetic plasmids Grant 8,563,302 - Draghia-Akli , et al. October 22, 2	2013-10-22
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications Grant 8,481,504 - Rabinovsky , et al. July 9, 2	2013-07-09
Constant current electroporation device and methods of use Grant 8,209,006 - Smith , et al. June 26, 2	2012-06-26
Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation Grant 8,188,056 - Draghia-Akli , et al. May 29, 2	2012-05-29
Gene therapy expression of GHRH for increasing RBC count in subjects Grant 8,178,504 - Draghia-Akli , et al. May 15, 2	2012-05-15
Growth hormone releasing hormone treatment to decrease cholesterol levels Grant 8,058,253 - Draghia-Akli , et al. November 15, 2	2011-11-15
Optimized high yield synthetic plasmids Grant 7,846,720 - Draghia-Akli , et al. December 7, 2	2010-12-07
Electrode assembly for constant-current electroporation and use Grant 7,664,545 - Westersten , et al. February 16, 2	2010-02-16
Smallpox Dna Vaccine And The Antigens Therein That Elicit An Immune Response App 20090304627 - Draghia-Akli; Ruxandra ; et al.	2009-12-10
Antibody Production Elicited By A Dna Vaccine Delivered By Electroporation App 20090156787 - Draghia-Akli; Ruxandra ; et al.	2009-06-18
Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide Grant 7,517,863 - Draghia-Akli , et al. April 14, 2	2009-04-14
Methods For Treating Viral Infection With Oral Or Injectibel Drug Solution App 20090074721 - Kim; Jong Joseph ; et al.	2009-03-19
Canine Specific Growth Hormone Releasing Hormone App 20080221034 - Draghia-Akli; Ruxandra	2008-09-11
Canine specific growth hormone releasing hormone Grant 7,361,642 - Draghia-Akli April 22, 2	2008-04-22
Codon optimized synthetic plasmids Grant 7,316,925 - Draghia-Akli , et al. January 8, 2	2008-01-08
Compositions for and Methods for Treating Hiv App 20070259014 - Kim; Jong Joseph	2007-11-08

Company Registrations

NCAGE Code	4SWB2	VGX PHARMACEUTICALS INC!DBA ADVISYS
CAGE Code	4SWB2	VGX PHARMACEUTICALS INC DBA ADVISYS

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.